{"slideshow_credits": null, "snippet": "The biotechnology giant Amgen, seeking to bolster its drug discovery efforts, said it would pay $415 million in cash to acquire deCODE Genetics, a gene-hunting firm based in Iceland.", "abstract": "The biotechnology giant Amgen, seeking to bolster its drug discovery efforts, said it would pay $415 million in cash to acquire deCODE Genetics, a gene-hunting firm based in Iceland.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://dealbook.nytimes.com/2012/12/10/amgen-to-acquire-gene-hunting-firm-decode/", "lead_paragraph": null, "headline": {"main": "Amgen to Acquire the Gene-Hunting Firm deCODE", "print_headline": "Amgen to Buy Firm Working On Gene Links To Diseases", "kicker": "DealBook"}, "_id": "50c5f82300315214fbb7e9fc", "word_count": "702", "multimedia": [], "pub_date": "2012-12-10T09:49:43Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "persons", "value": "Bradway, Robert A", "rank": "1"}, {"name": "organizations", "value": "Amgen Inc", "rank": "1"}, {"name": "organizations", "value": "DeCode Genetics", "rank": "2"}, {"name": "subject", "value": "Alzheimer's Disease", "rank": "1"}, {"name": "subject", "value": "Biotechnology", "rank": "2"}, {"name": "subject", "value": "Genetics and Heredity", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "4"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}